Spread the Word! April is Testicular Cancer Awareness Month

Spread the Word! April is Testicular Cancer Awareness Month

As the month of April brings testicular cancer into focus, its time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated testicular cancer information throughout the year.

The testicles are made up of different types of cells, each with the potential to develop into one or more types of cancer. The bulk of testicular cancers (90%), develop in cells known as germ cellsthe cells that make sperm. The two main types of germ cell tumors (GCTs) in men are seminomas and non-seminomas and they occur about evenly, and are further sub-typed from there.

In the US, the incidence rate of testicular cancer has been increasing for several decades without evidence pointing to any particular lead as to why. Still, testicular cancer is not common: about 1 in every 263 males will develop it. It can also usually be treated successfully, and a mans risk of dying from the disease is very low.

This doesnt mean that one shouldnt acquaint themselves with the possible risk factors and signs and symptoms of testicular cancer. April is the perfect month to do that. Help spread the word!


Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?

  • Sign up for monthly newsletters on testicular cancer here.
  • Get the facts about testicular cancer here.
  • Join ongoing discussions with other individuals affected by testicular cancer in the CancerConnect private online testicular cancer support group here.
  • Follow CancerConnect on Facebook and Twitter.



Testicular Cancer Online Support Group


[1] American Cancer Society. Cancer Facts and Figures 2016. Available at http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf. Accessed March 31, 2016.

Copyright © 2018 CancerConnect. All Rights Reserved.